This NDC is on FDA's drug shortage list (posted Jun 13, 2018)
Product Information
LIDOCAINE HCL 1% VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0700 per ML under NDC 00143957710. Its NADAC has been published 281 times since May 20, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143957710
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080407FDA Approved
Before 1982
TE Code
AP
On Market Since
2/14/1972
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% VIAL has been published 281 times since May 20, 2020, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0700 per ML |
|---|---|
| All-time high | $0.0853 (Apr 10, 2024) |
| All-time low | $0.0582 (Oct 18, 2023) |
| 52-week high | $0.0769 |
| 52-week low | $0.0681 |
| Median price | $0.0703 |
| Average price | $0.0696 |
| Largest weekly change | +46.6% (Dec 20, 2023) |
| Weeks tracked | 281 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0700 per ML (NDC 00143957710), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 1% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 4.4%. It has been tracked across 281 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?
Since May 20, 2020, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.0582 (Oct 18, 2023) to a high of $0.0853 (Apr 10, 2024), with a median of $0.0703 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0681 per ML — about 3% below LIDOCAINE HCL 1% VIAL.
Who manufactures LIDOCAINE HCL 1% VIAL?
LIDOCAINE HCL 1% VIAL (NDC 00143957710) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is LIDOCAINE HCL 1% VIAL in shortage?
Yes — NDC 00143957710 is currently listed in FDA's drug shortage database (posted Jun 13, 2018).